Advances in Antibody-Based Therapeutics for Cerebral Ischemia.

Sun, Jui-Ming; Yen, Ting-Lin; Jan, Jing-Shiun; Mwale, Pharaoh Fellow; Teng, Ruei-Dun; Taliyan, Rajeev; Hsieh, Cheng-Ta; Yang, Chih-Hao

Sun, Jui-Ming; Yen, Ting-Lin; Jan, Jing-Shiun; Mwale, Pharaoh Fellow; Teng, Ruei-Dun; Taliyan, Rajeev; Hsieh, Cheng-Ta; Yang, Chih-Hao.

Afiliação

Sun JM; Section of Neurosurgery, Department of Surgery, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chia-Yi City 600, Taiwan.
Yen TL; Department of Biotechnology, Asia University, Taichung City 41354, Taiwan.
Jan JS; Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan.
Mwale PF; Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan.
Teng RD; Department of Medical Research, Cathay General Hospital, Taipei 22174, Taiwan.
Taliyan R; Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan.
Hsieh CT; Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan.
Yang CH; Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, No. 250, Wu Hsing St., Taipei 110, Taiwan.

Pharmaceutics ; 15(1)2022 Dec 31.

Article em En | MEDLINE | ID: mdl-36678774

Palavras-chave

antibody; blood brain barrier; cerebral ischemia; hemorrhagic; ischemic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google